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To study the tumorigenesis of Epstein–Barr virus (EBV)-positive epithelial cell lines GT38 and GT39 derived from human gastric
tissues, we inoculated these cells under the skin of severe combined immunodeficient (SCID) mice. The development of tumors
was observed in each of the mice about 2 months after the inoculation. The tumors were diagnosed with undifferentiated
carcinoma by hematoxylin/eosin staining. EBV-encoded small RNA1 was detected in the paraffin-embedded tumor sections. The
tumor cells had human chromosome. The circular, but not linear, EBV DNA was detected in the tumors. The molecular sizes of EBV
DNA termini were the same as that of the inoculated GT38 or GT39 cells. The expressions of EBV nuclear antigen 2 and latent
membrane protein 1 reduced in the tumors. Transcripts of BamHI C and W promoters in latency III were detected in the tumors
and the cultured cells in vitro. The tumor cells were passaged from one SCID mouse to other SCID mice and to cultures in vitro.
This is the first evidence that the EBV-positive epithelial cell lines produced tumors in the SCID mouse. © 2000 Academic Press
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DINTRODUCTION
Recently there have been many reports suggesting the
role of Epstein–Barr virus (EBV) in the development of
certain cases of gastric carcinoma (Tokunaga et al.,
1993; Fukayama et al., 1994; Imai et al., 1994; Shousha
nd Luqmani, 1994; Harn et al., 1995; Iezzoni et al., 1995).
BV has been found in most cases of rare gastric lym-
hoepithelioma-like carcinoma (LELC) (Min et al., 1991;
hibata et al., 1991; Ohfuji et al., 1996) and a small but
ignificant proportion of common gastric adenocarci-
oma (Shibata and Weiss, 1992; Tokunaga et al., 1993).
he presence of EBV in gastric carcinoma has been
hown by polymerase chain reaction (PCR) for EBV DNA
Satoh et al., 1998) and in situ hybridization for EBV-
ncoded small RNA (EBER) (Shibata et al., 1991; Ohfuji et
l., 1996). In general it has been reported that the gastric
arcinoma cells express EBV nuclear antigen (EBNA) 1
nd EBER1, but not the other EBNAs or latent membrane
roteins (LMPs) (Fukayama et al., 1994; Imai et al., 1994).
To understand the role of EBV in epithelial cells, we
ried to establish EBV-positive epithelial cell lines from
BV-positive gastric carcinoma tissues. Recently we es-
ablished two EBV-infected epithelial cell lines, GT38 and
T39, from gastric tissues bearing carcinoma from the
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ressed at Department of Biosignaling, School of Life Science, Facultyl
f Medicine, Tottori University, Nishimachi 86, Yonago 683-8503, Japan.
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20atients, although they were derived from noncancerous
ortions of gastric carcinoma-tissues (Tajima et al.,
998). We characterized the cell property and EBV infec-
ion in the cell lines (Tajima et al., 1998; Takasaka et al.,
998; Gao et al., 1999; Kanamori et al., 2000). Both cell
ines were positive for cytokeratin, an epithelial marker,
ut not lymphocyte markers (Tajima et al., 1998). The
pontaneous EBV reactivation was observed in small
roportions in the cells and the infectious virus was
roduced from the cells (Takasaka et al., 1998). The EBV
nfection was referred to as latency type III because the
xpression of EBNA1, EBNA2, and LMP1 was detected in
he cells by Western blotting. A constitutive, low-level NO
ynthase mRNA was expressed in the cell lines and the
roduced NO was a regulatory factor in maintaining virus
atency via inhibiting EBV reactivation in the cells (Gao et
l., 1999). Both cell lines formed colonies in soft agar
Kanamori et al., 2000).
In this study, we investigated the tumorigenesis of the
ell lines in the severe combined immunodeficient
SCID) mouse to determine whether the cell lines have
he character of tumor cells. The present study describes
he tumorigenesis, the character of developed tumors,
nd the expression of EBV genes in the tumor cells.
RESULTS
evelopment of tumors in SCID miceTo study the tumorigenesis of GT38 and GT39 cell
ines, we inoculated them under the skin of SCID mice.
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21TUMORIGENESIS OF EBV-POSITIVE CELL LINES IN SCID MOUSEThe development of tumors in SCID mice was observed
at 45 and 56 days after inoculation of GT39 and GT38
cells, respectively (Fig. 1A). Both tumors were located
under the skin which had been inoculated with the cells.
No metastasis was observed in the mice.
Hematoxylin/eosin (H & E) staining and EBER in situ
ybridization
Both of the tumors with GT38 and GT39 cells were
iagnosed as undifferentiated carcinoma by H & E stain-
ng (Figs. 1B and 1D). No production of mucus was
bserved by periodic-acid-Schiff staining in the tumors
data not shown). There were vigorous proliferative cells
FIG. 1. Tumors in SCID mice inoculated with GT38 or GT39 cells. S
suspended in 3 ml of each culture supernatant. Tumors were found in
56 or 46 days, respectively. H & E staining and EBER in situ hybridizatio
EBER-positive cells appear to be dark brown.n the outside portion of the cardia of the tumors. EBV
nfection in the tumor cells was tested by EBER1 in situ
A
dybridization (Figs. 1C and 1E). EBER1 was detected in
he nuclei of the tumor cells and the strong signals were
etected in the same location of the proliferative cells.
ubular structures which were expected as mouse tis-
ues were seen in the surrounding tumor in the GT39-
noculated mouse (Fig. 1D). EBER1 was not detected in
he structures (Fig. 1E).
udgment on karyotype of human chromosome in the
umors
To confirm the human origin of tumors induced with
T38 and GT39 cells, we carried out Q-band staining of
hromosomes in the tumor cells cultured in vitro (Fig. 2).
ice were inoculated under the skin with 5 3 107 GT38 or GT39 cells
nks in GT38 (A) and GT39 (data not shown) cell-inoculated mice after
carried out for the tumors produced by GT38 (B, C) or GT39 (D, E) cells.CID m
both flas a rule the centromere of the human chromosome
oes not stain, although the mouse chromosome’s cen-
m
n
w
22 MURAKAMI ET AL.tromere does. Moreover, the mouse chromosome does
not have short arms, whereas human chromosome does.
We found that the centromeres were not stained in the
chromosomes of tumor cells induced by GT38 (Fig. 2A) or
GT39 (Fig. 2B), while they were stained in the mouse
chromosomes (Fig. 2C). Additionally, the chromosomes
of the tumor cells had short arms (Figs. 2A and 2B).
These results indicated that the tumors originated from
the inoculated GT38 and GT39 cells, respectively.
Detection of EBV DNA by Southern blot hybridization
The clonality of EBV genomes indicates cellular
clonality (Raab-Traub and Flynn, 1986). The clonality of
FIG. 2. Q-banding and quinacrine mustard/Hoechst staining. Chro-
osomes in the tumor cells inoculated with GT38 (A) or GT39 (B) had
o stained centromere after quinacrine mustard/Hoechst staining,
hile the mouse chromosome centromere (C) was stained.EBV genomes was analyzed in the tumors of SCID
mice by Southern blot hybridization (Fig. 3). Hybridiza-tion with an XhoI fragment identified a major 12-kb EBV
DNA restriction enzyme fragment in both the GT38
tumor (GT38T) and the GT39 tumor (GT39T; data not
shown) cells. No ladder of fragments representing
linear termini was detected in either GT38T or GT39T
(data not shown), whereas the ladder of fragments
was detected strongly in GT38 and weakly in the
cultured GT38T cells (GT38TC) on two passages at an
interval of 5 days in vitro.
Expression of EBV proteins
The expressions of EBNA2 and LMP1 were analyzed
in GT38, GT39, GT38T, GT39T, GT38TC, and GT39TC by
Western blotting (Fig. 4). EBNA2 was detected in GT38
and GT38TC, but not in GT38T, and was detected in
GT39, GT39T, and GT39TC, although the level in GT39T
was much lower. Thus the expression of EBNA2 clearly
reduced in both tumors.
The expression of LMP1 was detected in GT38 and
GT38TC; however, it was detected faintly in GT38T. On
the other hand, LMP1 was detected in GT39, GT39T, and
GT39TC. The reduction of LMP1 expression was clearly
observed in GT38T. The tumor cells were continuously
FIG. 3. Detection of the terminal restriction enzyme fragments of EBV
DNA. The Southern blot was prepared from the intracellular DNAs,
digested with BamHI, hybridized with the radiolabeled XhoI fragment. A
circular, 12-kb EBV DNA band was detected in each lane. The linear
form (arrowhead) of TR was detected in GT38 and GT38TC, but not in
GT38T.
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23TUMORIGENESIS OF EBV-POSITIVE CELL LINES IN SCID MOUSEcultivated in vitro and the expressions of EBNA2 and
LMP1 were always detected in the cultured cells (data
not shown).
Lytic antigens ZEBRA and EA-D were detected in GT38
and GT39, but not in GT38T, GT39T, GT38TC, or GT39TC
by Western blotting (data not shown).
EBNA gene transcription
To understand the reduced expression of EBNA2 pro-
tein in the tumor cells (GT38T and GT39T), the expres-
sion of EBNA2 mRNA was analyzed in GT38, GT39,
GT38T, GT39T, GT38TC, and GT39TC by reverse tran-
scription–polymerase chain reaction (RT-PCR; Fig. 5A).
The transcripts of EBNA2 were detected equally in all the
preparations.
Transcription for all the EBNAs can initiate from BamHI
C and/or W at the BamHI C and/or W promoters (Cp
and/or Wp) in latency III, while in latency I and II only
EBNA1 is expressed and the mRNA initiates at a pro-
moter within BamHI Q (Qp) (Rickinson and Kieff, 1996).
RNAs prepared from these cells were analyzed by RT-
PCR for EBNA1 transcription from Cp/Wp (Fig. 5B). The
Cp and Wp transcripts were detected in all preparations
from the different sources, whereas no Qp transcript was
detected in any of the preparations (data not shown).
These results indicate that the reduction of EBNA2 pro-
tein in GT38T and GT39T and LMP1 protein in GT38T
was not due to the change of latency pattern of transcrip-
tion from latency III to latency I.
DISCUSSION
The oncogenic potential of GT38 and GT39 cell lines
has been suggested by the ability of colony formation in
FIG. 4. Detection of EBNA2 and LMP1 by Western blotting. The
expressions of EBNA2 and LMP1 were analyzed in GT38 and GT39,
their tumors (GT38T, GT39T), and cultured cells (GT38TC, GT39TC).
EBV-transformed B cells (LCL) and an EBV genome-negative gastric
carcinoma cell line MKN1 were used as the positive and negative
controls, respectively. The same amount (15 mg) of protein was loaded
on each lane and electrophoresed.soft agar (Kanamori et al., 2000). The present study dem-
onstrated that the tumors developed in SCID mice that
R
ahad been inoculated with GT38 and GT39 cells. The
tumors were needed to prevent the possibility of mouse
cells becoming infected by EBV from the inoculated cell
lines and growing as tumors, although EBV infection is
restricted to human and other primates under normal
circumstances. We detected the human karyotype in
tumor cells. These facts demonstrate that GT38 and
GT39 cells have oncogenic potential in the SCID mouse.
This is the first evidence of the tumorigenesis in the
SCID mouse on EBV-positive epithelial cell lines derived
from gastric tissues, even though many previous studies
reported on EBV-infected B cells in SCID mice (Rowe et
al.,1991; Maria et al.,1992).
These tumors were solid carcinoma and were clearly
different from EBV-positive B-cell lymphoma in the SCID
mouse (Rowe et al., 1991; Maria et al.,1992). GT38T was
orphologically similar to undifferentiated LELC, al-
hough the infiltration of lymphoid cells, which is seen in
ELC, did not occur. The similarity to LELC is interesting,
ecause EBV infection is detected with a high frequency
n LELC (Min et al., 1991; Shibata et al., 1991; Ohfuji et al.,
1996).
EBV DNA was detected in the tumors developed in
SCID mice by Southern blot hybridization. The EBV DNA
bands showed a monoclonal EBV genome by the termi-
nal repeat (TR) analysis of EBV DNA (Fig. 3). The molec-
ular size of TR was consistent with that of a previous
report that both GT38 and GT39 had a single clonotype of
EBV DNA (Takasaka et al., 1998). A ladder of fragments
representing linear termini was not detected in the tumor
cells; however, it was detected in the cultured cells in
vitro. These results may suggest that EBV reactivation
FIG. 5. Analysis of RT-PCR of EBNA2 transcript and promoter usage
for EBNA gene transcription. Total cellular RNAs from cells and tissues
were subjected to RT-PCR analysis followed by Southern hybridization
with 32P-labeled probes. (A) EBNA2 transcript was analyzed in the
ndicated cells by RT-PCR. (B) The structures of EBNA1 mRNA tran-
cribed from the two different promoters, Wp and Cp, were analyzed.
aji and LCL (EBV-transformed B-cell line) and Ramos cells were used
s the positive and negative controls, respectively.
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24 MURAKAMI ET AL.dose not occur in vivo, but is induced in the condition in
itro. This phenomenon was observed in EBV-positive B
ells. EBV was harbored in peripheral lymphocytes of
nfectious mononucleosis patients as a nonproductive
atent infection, which is activated to produce virus in
itro (Rickinson et al., 1974). The common pathways for
BV reactivation may be transduced in the cultures in
itro.
The expression of EBNA2 and LMP1 proteins was also
ifferent between the cultured cells and the tumor cells
Fig. 4). In agreement with the classification of EBV la-
ency (Raab-Traub and Flynn, 1986), GT38 and GT39 cells
ere classified as EBV latency type III (Takasaka et al.,
998). Interestingly, the EBNA2 and LMP1 expressions in
T38T were not detected by Western blotting, whereas
he proteins were detected in both GT38 and the cultured
umor cells GT38TC. The decreased expression of
BNA2 was also seen in the serially passaged tumors of
T38T (data not shown). It was surprising because the
BV latency in GT38T was phenotypically latency type I,
hich is seen in gastric carcinoma (Fukayama et al.,
994; Imai et al., 1994; Iwasaki et al., 1998). However, the
ranscript of EBNA2 was detected equally in the cultured
ells and tumor cells and the analysis of EBNA1 promot-
rs demonstrated that Cp/Wp promoters were tran-
cribed similarly in both cultured cells and tumor cells.
he difference of EBV gene expression was also ob-
erved in EBER expression in the tumors. The signals of
BER were stronger in vigorous proliferative cells in the
utside portion of cardia of tumors (Fig. 1). Necrosis was
bserved in the cardia portions of some tumors which
rew over in SCID mice. The reduction of EBNA2, LMP1,
nd EBER expression may be the result of the reduced
ell growth and cell death of tumors in SCID mice.
We have not tested in detail the efficiency of tumor
evelopment, but it seems to be high, because the tumor
lways developed in all mice inoculated with either GT38
r GT39 cells at 5 3 107 cells/mouse. Moreover, these
tumors were serially passaged from mouse to mouse.
EBER was always detected in the tumor cells which
carried out several passages in SCID mice. This fact
indicates that the oncogenic potential of GT38 and GT39
cells did not change during passage in vitro and in vivo.
Although GT38 and GT39 cell lines have the character
of tumor cells, their origin from noncancerous portions
and the latency type III suggest that GT38 and GT39 cell
lines may not have originated from gastric carcinoma
cells. What are the original cells? One of the possibilities
is that they originate from EBV-infected noncarcinoma-
tous gastric epithelium. Yanai and colleagues (1997) re-
ported that gastric epithelium is frequently infected with
EBV and suggested that prolonged EBV persistence may
contribute to the development of gastric carcinoma. An-
other possibility is that they originate from normal gastric
epithelial cells, which are infected in vitro with EBV from
other EBV-infected cells, such as the carcinoma or non-
a
pcarcinomatous gastric epithelium, and immortalized as
the cell lines. Recently it was demonstrated that EBV
infection causes a transformed phenotype on primary
gastric epithelial cells in vitro (Nishikawa et al., 1999).
The tumor development in the SCID mouse will be a
useful animal model for studying EBV-infected epithelial
cell tumors, such as gastric carcinoma and nasopharyn-
geal carcinoma, and will give us valuable ideas for un-
derstanding EBV infection in epithelial cells on the mo-
lecular level.
MATERIALS AND METHODS
Cell cultures
GT38 and GT39 cell lines were maintained in RPMI
1640 medium (Nissui Pharmaceutical, Tokyo, Japan) con-
taining 10% heat-inactivated fetal bovine serum, 100
mg/ml of streptomycin, and 100 U/ml penicillin. Cultures
were treated with 0.25% trypsin and 100 mM EDTA on
passage, and incubated at 37°C in humidified air with 5%
CO2.
noculation of cell lines to SCID mice
SCID mice were purchased from Clea Japan (Tokyo,
apan). The mice were maintained in the infected animal
aboratory (pathogen-free conditions) at the Animal Re-
earch Center at the Faculty of Medicine, Tottori Univer-
ity. Six-week-old female SCID mice were inoculated
nder the skin with 5 3 107 cells suspended in 3 ml of
the cell culture supernatant.
Q-banding/Hoechst staining
Karyotype was checked by quinacrine/Hoechst double
staining (Caspersson et al., 1970). Cells were treated
with colcemid (0.05 mg/ml) for 2 h, washed with phos-
hate-buffered saline (PBS), and centrifuged at 1200 rpm
or 5 min at room temperature. The pellet was mixed with
5 mM KCl reacted for 15 min, fixed with acetic acid and
ethanol at a ratio of 1:3, and then centrifuged at 1200
pm for 5 min. The pellet was suspended in the acetic
cid and methanol solution, then spread onto metaphase
hromosome-prepared air-dried slides. The slides were
tained as follows. First, the slides were soaked in McIl-
aine buffer I, soaked in quinacrine solution for 15 min,
nd washed with water. Second, the slides were soaked
n McIlvaine buffer II, soaked in Hoechst 33258 staining
olution for 20 min, and washed with water. Third, the
lides were soaked in McIlvaine buffers II and III. They
ere then covered with a coverslip and observed under
fluorescence microscope.
n situ hybridization for EBER
In situ hybridization for EBER was carried out in par-
ffin-embedded tissue sections using an antisense
robe for EBER as previously described (Tokunaga et al.,
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25TUMORIGENESIS OF EBV-POSITIVE CELL LINES IN SCID MOUSE1993). H & E staining was done in the sections for
histological analysis of tumors.
Southern blotting
DNA was extracted from tumor tissues and cultured
cells. To analyze the TR of EBV DNA in cells (Raab-Traub
and Flynn, 1986), extracted DNA was digested with
BamHI, and Southern blotting was done to detect the
termini of EBV DNA with a 32P-labeled XhoI fragment
probe as described previously (Takasaka et al., 1998).
Western blotting
EBNA2 and LMP1 were detected by Western blotting.
Tumor tissues were minced by razors in dishes with
ice-cold PBS/10% trichloroacetic acid. The minced tumor
cells and cultured cells were washed twice with ice-cold
PBS/10% trichloroacetic acid, incubated on ice for 15 min,
and centrifuged at 15,000 rpm at 4°C for 5 min. The
pellets were lysed in 50 ml of lithium dodecylsulfate
(LDS) sample buffer (125 mM Tris–HCl, pH 6.8, 2.3% [w/v]
LDS, 10% [w/v] glycerol, 5% [v/v] 2-mercaptoethanol, 10
mg/ml bromphenol blue) and neutralized with 2 M Tris–
HCl, pH 12 and boiled for 5 min. These samples were
resolved by SDS–10% polyacrylamide gel electrophore-
sis (PAGE), and transferred to a PVDF membrane (Milli-
pore, Bedford, MA). The membranes were reacted with
mouse antibodies to LMP1 (Dako Japan, Kyoto, Japan),
EBNA2 (Dako Japan), or ZEBRA (developed in our labo-
ratory) for the first antibody and an alkaline-phospha-
tase-conjugated anti-mouse antibody (New England Bio-
T
Oligonucleotides U
Transcripts Primer sequences
EBNA2
59 primer GCTGCTACGCATTAGAGACC
39 primer TCCTGGTAGGGATTCGAGGG
probe CAGCACTGGCGTGTGACGTGGTGT
Wp
59 primer (W0W1) CAGGAGATCTGGAGTCCACACAAA
59 primer (W0W19) GAGGAGATCTGGAGTCCACACAAA
39 primer (W2) ACTGAAGCTTGACCGGTGCCTTCTT
probe (W1h) GAGACCGAAGTGAAGGCCCTGGAC
Cp
59 primer (C1) TGTAGATCTGATGGCATAGAGAC
39 primer (W2) ACTGAAGCTTGACCGGTGCCTTCTT
probe (C1h) AAGGACACCGAAGACCCCCAGAG
Qp
59 primer (Q) ATATGAGCTCGTGCGCTACCGGATG
39 primer (K) GATCGAATTCCATTTCCAGGTCCTG
probe (Uh) GGTGAATCTGCTCCCAGGTC
a Oligonucleotide sequences used for PCR analysis for detection of
b Coordinates refer to genomic map of B95-8 virus.labs, Beverly, MA) for the second antibody. The bands
were visualized by using a combination of Nitro-block
w
T(Tropix, Bedford, MA) and CSPD (Boeringer Mannheim,
Mannheim, Germany), and were exposed to X-ray film
(Eastman Kodak, Rochester, NY).
RNA isolation
Total cellular RNAs form cultured cells and tissues
were extracted using Isogen reagent (Nippon Gene, To-
kyo, Japan) according to the manufacturer’s protocol.
Briefly, cells were lysed in the Isogen reagent. The ho-
mogenates of the cell lysates of the tissues were kept at
room temperature for 5 min and then treated with 0.2 ml
chloroform for 3 min. The mixture was centrifuged at
12,000 rpm for 10 min at 4°C. The upper aqueous phase
was collected, treated with 0.5 ml isopropanol for 10 min,
and centrifuged for 10 min at 4°C. The RNA pellets were
washed in 75% ethanol, dried, and dissolved in diethyl
pyrocarbonate-treated distilled water. All RNA samples
had an OD260/OD280 ratio . 1.50.
T-PCR analysis
For cDNA synthesis, 10 pmol of a 39-primer specific for
ach transcript was added to the RNA sample (1 mg).
everse transcription was performed using an M-MLV
everse transcriptase kit (Gibco BRL, Grand Island, NY)
nd Ready-To-Go first-strand cDNA kit (Pharmacia Bio-
ech, Tokyo, Japan) as recommended by the manufac-
urer. Reverse transcription was performed at 37°C for 60
in in a total volume of 20 ml, then heated at 95°C for 5
in to stop the reaction and denatured the reverse tran-
criptase, and cooled on ice for 5 min. These products
RT-PCR Analysisa
Product size (bp) EBV genome coordinatesb
339 47892–47911
48616–48597
48391–48420
131/136 14396–14556
14396–14561
G 14735–14716
C 14561–14590
285/290 11342–11355
G 14735–14716
11356–11378
255 62441–62457
107987–107967
67628–67609
RNA.ABLE 1
sed for
AAGTT
TCCT
TGGG
AGGA
CAACC
AGGA
GCG
TACCTere used to analyze promotor and EBNA2 expression.
he PCR products were electrophoresed in 5% acrylamid
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26 MURAKAMI ET AL.gels, stained with ethidium bromide, and photographed
under a UV-transilluminator. Full details of the se-
quences and genome coordinates of primers and probes
used to detect EBV transcripts are given in Table 1. Our
primer pairs were designed in different exons for indi-
vidual EBV transcripts so that occasional amplification of
contaminated genomic DNA, if any, could be easily dis-
criminated from the relevant RNA amplification by prod-
uct size. They were blotted onto a nylon membrane
(Amersham, Buckinghamshire, UK) by electric transfer
and subjected to hybridization with [g-32P]ATP 59-end-
labeled internal oligonucleotide probes.
ACKNOWLEDGMENTS
This work was supported by Grants-in-Aid Scientific Research on
Carcinogenesis in Priority Areas from the Ministry of Education, Sci-
ence, Sports, and Culture of Japan, and the Japan Health Science
Foundation; the Second-Term Comprehensive 10-Year Strategy for Can-
cer Control from the Ministry of Health and Welfare of Japan; and the
Special Coordination Funds for the Science and Technology from
Science and Technology Agency (STA). We are grateful to Dr. Masashi
Fukayama for the XhoI fragment. We thank Ms. Shoko Takehara for
assistance in chromosome analysis and Ms. Sayuri Matsumoto for
typing the manuscript.
REFERENCES
Caspersson, T., Zech, L., and Jojansson, C. (1970). Analysis of human
metaphase chromosomes by aid of DNA binding fluorescent agents.
Exp. Cell. Res. 62, 490–492.
Fukayama, M., Hayashi, Y., Iwasaki, Y., Chong, J., Ooba, T., Takizawa, T.,
Koike, M., Mizutani, S., Miyaki, M., and Hirai, K. (1994). Epstein-Barr
virus associated gastric carcinoma and Epstein-Barr virus infection
of the stomach. Lab. Invest. 71, 73–81.
ao, X., Tajima, M., and Sairenji, T. (1999). Nitric oxide down-regulates
Epstein-Barr virus reactivation in epithelial cell lines. Virology 258,
375–381.
arn, H. J., Chang, J. Y, Wang, M. W., Ho, L. I., Lee, H. S., Chiang, J. H.,
and Lee, W. H. (1995). Epstein-Barr virus-associated gastric adeno-
carcinoma in Taiwan. Hum. Pathol. 26, 267–271.
ezzoni, J. C., Gaffey, M. J., and Weiss, L. M. (1995). The role of Epstein-
Barr virus in lymphoepithelioma-like carcinomas. Am. J. Clin. Pathol.
103, 308–315.
mai, S., Koizumi, S., Sugiura, M., Tokunaga, M., Uemura, Y., Yamamoto,
N., Tanaka, S., Sato, E., and Osato, T. (1994). Gastric carcinoma:
Monoclonal epithelial malignant cells expressing Epstein-Barr virus
latent infection protein. Proc. Natl. Acad. Sci. USA 91, 9131–9135.
wasaki, Y., Chong, J, M., Hayashi, Y., Ikeno, R., Arai, K., Kitamura, M.,
Koike, M., Hirai, K., and Fukayama, M. (1998). Establishment and
characterization of a human Epstein-Barr virus-asociated gastric
carcinoma in SCID mice. J. Virol. 72, 8321–8326.
anamori, M., Tajima, M., Satoh, Y., Hoshikawa, Y., Miyazawa, Y., Oki-
naga, K., Kurata, T., and Sairenji, T. (2000). Differential effect of TPA on
cell lines growth, and Epstein-Barr virus reactivation in epithelial cell
lines derived from gastric tissues and B cell line Raji. Virus Genes 20,
117–125.
aria, L. V., Arianna, V., Emma, D., Annarosa, D. M., Stefano, I., Maria,C. B. (1992). Lymphoproliferative disease in human peripheral blood
mononuclear cell-injected SCID mice. I. T lymphocyte requirement
for B cell tumor generation. J. Exp. Med. 176, 1763–1767.
in, K. W., Holmquist, S., Peoper, S. C., and O’Leary, T. J. (1991). Poorly
differentiated adenocarcinoma with lymphoid stroma (lympho-epi-
thelioma-like carcinoma) of the stomach. Report of three cases with
Epstein-Barr virus genome demonstrated by the polymerase chain
reaction. Am. J. Clin. Pathol. 96, 219–227.
Nishikawa, J., Imai, S., Oda, T., Kojima, T., Okita, K., and Takada, K.
(1999). Epstein-Barr virus promotes epithelial cell growth in the
absence of EBNA2 and LMP1 expression. J. Virol. 73, 1286–1292.
Ohfuji, S., Osaki, M., Tujitani, S., Ikeguchi, M., Sairenji, T., and Ito, H.
(1996). Low frequency of apoptosis in Epstein-Barr virus-associated
gastric carcinoma with lymphoid stroma. Int. J. Cancer 68, 710–715.
Raab-Traub, N., and Flynn, K. (1986). The structure of the termini of the
Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 47,
883–889.
ickinson, A. B., Jarvis, J. E., Crawford, D. H., and Epstein, M. A. (1974).
Observations on the type of infection by Epstein–Barr virus in pe-
ripheral lymphoid cells of patients with infectious mononucleosis. Int.
J. Cancer 14, 704–715.
ickinson, A. B., and Kieff, E. (1996). Epstein–Barr virus. In “Fields’
Virology” (B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock,
M. S. Hirsh, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus,
Eds.), Vol. 2, 3rd ed., pp. 2397–2445. Lippincott-Raven, Philadelphia.
owe, M., Young, L. S., Crocker, J., Stokes, H., Henderson, S., and
Rickinson, A. B. (1991). Epstein-Barr virus-associated lymphoprolif-
erative disease in the SCID mouse model: Implications for the
pathogenesis of EBV-positive lymphomas in man. J. Exp. Med. 173,
147–158.
atoh, Y., Takasaka, N., Hoshikawa, Y., Osaki, M., Ohfuji, S., Ito, H.,
Kaibara, N., Kurata, T., and Sairenji, T. (1998). Pretreatment with
restriction enzyme or bovine serum albumin for effective PCR ampli-
fication of Epstein-Barr virus DNA in DNA extracted from paraffin-
embedded gastric carcinoma tissue. J. Clin. Microbiol. 36, 3423–
3425.
hibata, D., Tokunaga, M., Uemura, Y., Sato, E., Tanaka, S., and Weiss,
L. M. (1991). Association of Epstein-Barr virus with undifferentiated
gastric carcinomas with intense lymphoid infiltration carcinoma.
Am. J. Pathol. 139, 469–474.
hibata, D., and Weiss, L. M. (1992). Epstein-Barr virus-associated
gastric adenocarcinoma. Am. J. Pathol. 140, 769–774.
housha, S., and Luqmani, Y. A. (1994). Epstein-Barr virus in gastric
carcinoma and adjacent normal gastric and duodenal mucosa.
J. Clin. Pathol. 47, 695–698.
ajima, M., Komuro, M., and Okinaga, K. (1998). Establishment of Ep-
stein-Barr virus-positive human gastric epithelial cell lines. Jpn. J.
Cancer Res. 89, 262–268.
akasaka, N., Tajima, M., Okinaga, K., Satoh, Y., Hoshikawa, Y., Kat-
sumoto, T., Kurata, T., and Sairenji, T. (1998). Productive infection of
Epstein-Barr virus (EBV) in EBV-genome-positive epithelial cell lines
(GT38 and GT39) derived from gastric tissues. Virology 247, 152–159.
okunaga, M., Uemura, Y., Tokudome, T., Ishidate, T., Masuda, H.,
Okazaki, E., Kaneko, K., Naoe, S., Ito, M., Okamura, A., Shimada, A.,
Sato, E., and Land, C. E. (1993). Epstein-Barr virus related gastric
cancer in Japan: A molecular patho-epidemiological study. Acta
Pathol. Jpn. 43, 574–581.
anai, H., Takada, K., Shimizu, N., Mizugaki, Y., Tada, M., and Okita, K.
(1997). Epstein-Barr virus infection in non-carcinomatous gastric ep-R. M., Marta, M., Rita, Z., Chiara, M., Marina, P., Alberto, A., and Luigi, ithelium. J. Pathol. 183, 293–298.
